Department of Pediatrics, School of Medicine, Tufts University and Tufts Medical Center, Boston, Massachusetts.
Department of Pediatrics, School of Medicine, Tufts University and Tufts Medical Center, Boston, Massachusetts
Pediatrics. 2020 Aug;146(2). doi: 10.1542/peds.2020-0251.
Despite the established safety and efficacy of the measles-mumps-rubella vaccine after almost 50 years of widespread use, the United States is encountering higher levels of measles and mumps disease than has occurred for years. Return of disease threatens the health of those who remain unimmunized by choice as well as those who are immunized appropriately but experience loss of vaccine-induced immunity. The solution to continued threats of illness caused by these untreatable but readily preventable diseases is compliance with recommendations for administration of the measles-mumps-rubella vaccine. Here we examine trends in the epidemiology of measles, mumps, and rubella in recent years and consider the consequences of loss of protective immunity within our country.
尽管麻疹-腮腺炎-风疹疫苗在近 50 年的广泛使用中已经确立了安全性和有效性，但美国麻疹和腮腺炎的发病率却高于多年来的水平。疾病的再次出现威胁到那些选择不接种疫苗的人的健康，也威胁到那些接种了疫苗但疫苗诱导的免疫力丧失的人的健康。解决这些无法治愈但容易预防的疾病持续带来的疾病威胁的方法是遵守麻疹-腮腺炎-风疹疫苗接种的建议。在这里，我们研究了近年来麻疹、腮腺炎和风疹的流行病学趋势，并考虑了我国保护性免疫丧失的后果。
